0
Obstructive Lung Diseases: COPD Pharmacotherapy |

Evaluation of Glycopyrronium Therapy in Chinese Patients Versus Predominantly Caucasian Populations in Patients With Moderate-to-Severe COPD: Comparison of Clinical Data

Chen Wang, MD; Tieying Sun, MD; Yijiang Huang, MD; Michael Humphries, MD; Lingyan Bai, MD; Lilly Li, MD; Qian Wang, MD; Zi Lin, MD; Peter D'Andrea, MD; Pablo Altman, MD
Author and Funding Information

China-Japan Friendship Hospital, Beijing, China


Copyright 2016, American College of Chest Physicians. All Rights Reserved.


Chest. 2016;149(4_S):A390. doi:10.1016/j.chest.2016.02.405
Text Size: A A A
Published online

Extract

SESSION TITLE: COPD Pharmacotherapy

SESSION TYPE: Original Investigation Poster

PRESENTED ON: Saturday, April 16, 2016 at 11:45 AM - 12:45 PM

PURPOSE: Glycopyrronium (GLY) is a once daily (od) long-acting muscarinic antagonist (LAMA) for maintenance treatment for patients with moderate-to-severe chronic obstructive pulmonary disease (COPD). The GLOW7 study studied the efficacy and safety of GLY 50µg od in Asian (predominantly Chinese) patients. We report here a comparison of the efficacy and safety of GLY in the Chinese cohort in the GLOW7 study vs results in predominantly Caucasian populations (GLOW1 and GLOW2 studies) with similar severity of COPD.

First Page Preview

View Large
First page PDF preview

Sign In to Access Full Content

MEMBER & INDIVIDUAL SUBSCRIBER

Want Access?

NEW TO CHEST?

Become a CHEST member and receive a FREE subscription as a benefit of membership.

Individuals can purchase this article on ScienceDirect.

Individuals can purchase a subscription to the journal.

Individuals can purchase a subscription to the journal or buy individual articles.

Learn more about membership or Purchase a Full Subscription.

INSTITUTIONAL ACCESS

Institutional access is now available through ScienceDirect and can be purchased at myelsevier.com.

Sign In to Access Full Content

MEMBER & INDIVIDUAL SUBSCRIBER

Want Access?

NEW TO CHEST?

Become a CHEST member and receive a FREE subscription as a benefit of membership.

Individuals can purchase this article on ScienceDirect.

Individuals can purchase a subscription to the journal.

Individuals can purchase a subscription to the journal or buy individual articles.

Learn more about membership or Purchase a Full Subscription.

INSTITUTIONAL ACCESS

Institutional access is now available through ScienceDirect and can be purchased at myelsevier.com.

Figures

Tables

References

NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).

Some tools below are only available to our subscribers or users with an online account.

Sign In to Access Full Content

MEMBER & INDIVIDUAL SUBSCRIBER

Want Access?

NEW TO CHEST?

Become a CHEST member and receive a FREE subscription as a benefit of membership.

Individuals can purchase this article on ScienceDirect.

Individuals can purchase a subscription to the journal.

Individuals can purchase a subscription to the journal or buy individual articles.

Learn more about membership or Purchase a Full Subscription.

INSTITUTIONAL ACCESS

Institutional access is now available through ScienceDirect and can be purchased at myelsevier.com.

Related Content

Customize your page view by dragging & repositioning the boxes below.

Find Similar Articles
CHEST Journal Articles
  • CHEST Journal
    Print ISSN: 0012-3692
    Online ISSN: 1931-3543